{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:38:53Z","timestamp":1790815133495,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3068,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.fertnstert.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T20:27:05Z","timestamp":1382041625000},"page":"112-119.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in\u00a0vitro fertilization: a noninferiority randomized controlled study"],"prefix":"10.1016","volume":"101","clinical-trial-number":[{"clinical-trial-number":"nct00827983","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Gillian","family":"Lockwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"de Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Strina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Molgora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Artini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Cela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pluchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibale","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"la Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Sighinolgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gianaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Grugnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"de Geyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Urbancsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abey","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacoub","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Engl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.09.010_bib1","first-page":"CD009154","article-title":"Luteal phase support for assisted reproduction cycles","volume":"5","author":"van der Linden","year":"2011","journal-title":"Cochrane"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(01)00134-6","article-title":"Impact of ovarian stimulation on corpus luteum function and embryonic implantation","volume":"55","author":"Tavaniotou","year":"2002","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(00)01497-7","article-title":"Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers","volume":"74","author":"Levine","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/TCRM.S4192","article-title":"Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin(R) (progesterone) vaginal insert","volume":"5","author":"Check","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0015-0282(01)02872-2","article-title":"A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles","volume":"76","author":"Propst","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0015-0282(01)01901-X","article-title":"A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles","volume":"76","author":"Costabile","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib8","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/humrep\/14.10.2596","article-title":"A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles","volume":"14","author":"Lightman","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.11.018","article-title":"Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial","volume":"97","author":"Silverberg","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/humrep\/15.suppl_1.129","article-title":"Progesterone for the luteal support of assisted reproductive technologies: clinical options","volume":"15","author":"Posaci","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0029-7844(97)00270-6","article-title":"Transvaginal administration of progesterone","volume":"90","author":"Fanchin","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0015-0282(16)54680-9","article-title":"Absorption of micronized progesterone from a nonliquefying vaginal cream","volume":"56","author":"Kimzey","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0015-0282(16)58226-0","article-title":"Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women","volume":"65","author":"Cicinelli","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib14","series-title":"Progesterone","first-page":"3273","author":"AHFS","year":"2011"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0015-0282(16)54713-X","article-title":"Comparative bioavailability of orally and vaginally administered progesterone","volume":"56","author":"Norman","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10847-006-9174-2","article-title":"Water soluble progesterone-hydroxypropyl-b-cyclodextrin complex for injectable formulations","author":"Zoppetti","year":"2007","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2013.05.029","article-title":"A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25mg and 50 mg of progesterone in aqueous preparation","volume":"100","author":"de Ziegler","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09513590.2012.736560","article-title":"Pharmacokinetics and safety profile of a novel progesterone aqueous formulation administered by the s.c. route","volume":"29","author":"Sator","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib19","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/jc.2008-0460","article-title":"Endometrial development and function in experimentally induced luteal phase deficiency","volume":"93","author":"Usadi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.fertnstert.2011.07.1097","article-title":"Hormonal induction of endometrial receptivity","volume":"96","author":"Paulson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2013.05.029","article-title":"A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation","volume":"100","author":"de Ziegler","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib22","series-title":"Yen and Jaffe's Reproductive Endocrinology","first-page":"125","article-title":"The synthesis and metabolism of steroids hormones","author":"Strauss","year":"2004"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0015-0282(16)56758-2","article-title":"The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials","volume":"61","author":"Soliman","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib24","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","article-title":"Luteal phase support in infertility treatment: a meta-analysis of the randomized trials","volume":"17","author":"Pritts","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib25","first-page":"CD004830","article-title":"Luteal phase support in assisted reproduction cycles","author":"Daya","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.fertnstert.2009.02.018","article-title":"A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone","volume":"92","author":"Zarutskie","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rbmo.2012.04.005","article-title":"Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey","volume":"25","author":"Vaisbuch","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Andersen","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7827-10-107","article-title":"The optimal duration of progesterone supplementation in pregnant women after IVF\/ICSI: a meta-analysis","volume":"10","author":"Liu","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/humrep\/den012","article-title":"Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks","volume":"23","author":"Aboulghar","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib31","first-page":"403","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"Cicinelli","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib32","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","volume":"94","author":"Yanushpolsky","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1067\/mob.2000.105738","article-title":"Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion","volume":"183","author":"Donders","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib34","first-page":"885","article-title":"Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis","volume":"48","author":"Flynn","year":"1999","journal-title":"J Fam Pract"},{"key":"10.1016\/j.fertnstert.2013.09.010_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.fertnstert.2011.12.020","article-title":"Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support","volume":"97","author":"Engmann","year":"2012","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213030604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213030604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:38:09Z","timestamp":1771393089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213030604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0015028213030604"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.09.010","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in\u00a0vitro fertilization: a noninferiority randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}